MicroRNAs (miRs), a class of small non-coding RNAs, function as key regulators in gene expression through binding to the 3'‑untranslated region (UTR) of their target mRNA, which further leads to translational repression or mRNA degradation. Recently, miR‑138 has been found to have a tumor suppressive role in a variety of human malignancies. However, the exact role of miR‑138 in regulating the malignant phenotypes of osteosarcoma (OS) has remained to be elucidated. In the present study, reverse‑transcription PCR analysis showed that the expression of miR‑138 was markedly reduced in OS tissues compared to that in matched adjacent non‑tumorous tissues. Furthermore, it was also downregulated in several common OS cell lines, when compared with that in a normal human osteoblast cell line. Overexpression of miR‑138 suppressed cell proliferation and invasion and led to a significant decrease in the protein expression of sirtuin 1 (SIRT1), which was further identified as a direct target gene of miR‑138 in MG63 cells. Moreover, restoration of SIRT1 expression reversed the suppressive effects of miR‑138 on MG63 cell proliferation and invasion. Finally, the expression of SIRT1 was found to be significantly upregulated in OS tissues compared to that in matched adjacent tissues, and SIRT1 levels were inversely correlated with the miR‑138 levels in OS tissues. Therefore, the present study demonstrated that miR‑138 has a role in inhibiting OS cell proliferation and invasion via directly targeting SIRT1, and suggested that the miR‑138/SIRT1 axis may become a promising therapeutic target for OS.

Related Articles